Diferencia entre revisiones de «EBQ:ADAPT Trial 2-Hour Troponin Rule Out»
m (Ostermayer moved page EBQ:ADAPT: 2-Hour Troponin Rule Out to EBQ:ADAPT Trial 2-Hour Troponin Rule Out) |
Sin resumen de edición |
||
| Línea 17: | Línea 17: | ||
==Clinical Question== | ==Clinical Question== | ||
Can an accelerated diagnostic protocol (ADP) for chest pain be used to identify low-risk patients suitable for discharge with close followup? | |||
==Conclusion== | ==Conclusion== | ||
An ADP can successfully identify low risk chest pain patients for discharge from the emergency department and decrease observational stay. | |||
==Major Points== | ==Major Points== | ||
| Línea 48: | Línea 50: | ||
==CME== | ==CME== | ||
<quiz display=simple> | |||
</quiz> | |||
==Sources== | ==Sources== | ||
Revisión del 05:49 11 ene 2014
incomplete Journal Club Article
Than M.. "2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial". Journal of the American College of Cardiology. 2012. 59(23):2091-2098.
PubMed Full text PDF
PubMed Full text PDF
Clinical Question
Can an accelerated diagnostic protocol (ADP) for chest pain be used to identify low-risk patients suitable for discharge with close followup?
Conclusion
An ADP can successfully identify low risk chest pain patients for discharge from the emergency department and decrease observational stay.
Major Points
Guidelines
Design
Population
Inclusion Criteria
Exclusion Criteria
Baseline Characteristics
Interventions
Outcomes
Primary Outcomes
Secondary Outcomes
Subgroup Analysis
Criticisms
Funding
CME